1. Home
  2. NXRT vs IVVD Comparison

NXRT vs IVVD Comparison

Compare NXRT & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Residential Trust Inc.

NXRT

NexPoint Residential Trust Inc.

HOLD

Current Price

$30.62

Market Cap

787.8M

Sector

Real Estate

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.86

Market Cap

659.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXRT
IVVD
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
787.8M
659.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NXRT
IVVD
Price
$30.62
$1.86
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$36.00
$8.75
AVG Volume (30 Days)
184.1K
3.4M
Earning Date
02-24-2026
03-19-2026
Dividend Yield
7.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$253,196,000.00
$50,039,000.00
Revenue This Year
N/A
$107.86
Revenue Next Year
$2.22
$146.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
332.71
52 Week Low
$27.69
$0.44
52 Week High
$43.13
$3.07

Technical Indicators

Market Signals
Indicator
NXRT
IVVD
Relative Strength Index (RSI) 53.51 37.03
Support Level $29.65 $2.15
Resistance Level $30.78 $2.31
Average True Range (ATR) 0.69 0.15
MACD -0.04 -0.05
Stochastic Oscillator 47.06 15.26

Price Performance

Historical Comparison
NXRT
IVVD

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: